AstraZeneca PLC (NYSE:AZN)
| 50.80 Delayed Data As of Jan 21 |  -0.53 / -1.03%Today’s Change | 35.30 Today|||52-Week Range 51.55 | +1.89% Year-to-Date |
Latest AZN News | Press Releases
| AstraZeneca and Merck Get an FDA Priority Review for Lynparza in Prostate Cancer Jan 21 / MotleyFool.com - Paid Partner Content | Here's Why Clovis Oncology Rose as Much as 25.6% Today Jan 15 / MotleyFool.com - Paid Partner Content |
| 2 Biotechs Battling Immune Diseases Jan 19 / MotleyFool.com - Paid Partner Content | FDA Gives Clovis Oncology's Rubraca a Priority Review Jan 15 / MotleyFool.com - Paid Partner Content |
| 5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals Jan 16 / MotleyFool.com - Paid Partner Content | Good News for Amarin: AstraZeneca Abandoning its Fish Oil Pill Jan 13 / MotleyFool.com - Paid Partner Content |
| High Drug Prices Remains a Top Issue in Democratic Debates Jan 15 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 51.33 |
| Today’s open | 50.48 |
| Day’s range | 50.48 - 51.04 |
| Volume | 1,964,105 |
| Average volume (3 months) | 3,005,916 |
| Market cap | $134.7B |
Data as of 6:30pm ET, 01/21/2020
Growth & Valuation
| Earnings growth (last year) | -29.11% |
| Earnings growth (this year) | +3.85% |
| Earnings growth (next 5 years) | +18.93% |
| Revenue growth (last year) | -2.88% |
| P/E ratio | 63.1 |
| Price/Sales | 4.36 |
| Price/Book | 10.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | +1.33 | +0.95% |
| ABBVAbbVie | -0.01 | -0.01% |
| SNYSanofi | -1.03 | -2.01% |
| GSKGlaxoSmithKline | -0.39 | -0.81% |
Data as of 6:30pm ET, 01/21/2020
Financials
| Next reporting date | February 14, 2020 |
| EPS forecast (this quarter) | $0.50 |
| Annual revenue (last year) | $22.1B |
| Annual profit (last year) | $2.2B |
| Net profit margin | 9.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
